Primary and secondary HIV-1 drug resistance mutations present in patients attending health centres in Maputo, Mozambique

被引：0
|
作者：
Ramalho, D. C. [1 ,2 ]
Abreu, C. [2 ]
Bullousa, L. [2 ]
Francisco, C. [1 ]
Jani, V. I. [1 ]
Bhatt, N. [1 ]
Ismael, N. [1 ]
Tanuri, A. [2 ]
Bila, D. C. [1 ]
机构：
[1] Inst Nacl Saude, Maputo, Mozambique
[2] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil
来源：
ANTIVIRAL THERAPY | 2011年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
103
引用
收藏
页码：A132 / A132
页数：1
相关论文
共 50 条
  • [41] HIV-1 drug resistance testing: health outcomes issues
    Youle, M
    Holtzer, C
    Simpson, K
    de Clerq, K
    Miller, V
    ANTIVIRAL THERAPY, 2000, 5 (02) : 113 - 115
  • [42] Patterns of anti-tuberculosis drug resistance among HIV-infected patients in Maputo, Mozambique, 2002-2003
    Nunes, EA
    De Capitani, EM
    Coelho, E
    Joaquim, OA
    Figueiredo, IRO
    Cossa, AM
    Panunto, AC
    Carvalho-Ramos, M
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (05) : 494 - 500
  • [43] HIV-1 drug resistance-associated mutations among antiretroviral-na ve Thai patients with chronic HIV-1 infection
    Manosuthi, W.
    Thongyen, S.
    Nilkamhang, S.
    Manosuthi, S.
    Sungkanuparph, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 140 - 140
  • [44] A SURVEILLANCE OF HIV-1 DRUG RESISTANCE MUTATIONS AMONG HIV-1 INFECTED VOLUNTARY BLOOD DONORS AND CLINICAL PATIENTS IN CHENGDU, SICHUAN, CHINA
    Zeng, P. B.
    Li, W. P.
    Liu, Y.
    He, M.
    Yuan, Y. H.
    Xu, M.
    Wang, J. X.
    VOX SANGUINIS, 2012, 103 : 173 - 173
  • [45] ARE LIVER TRANSPLANT HIV-1 INFECTED PATIENTS AT RISK TO DEVELOP HIV-1 DRUG RESISTANCE?
    Teicher, E.
    Desbois, D.
    Dussaix, E.
    Figueroa, M.
    Antonini, T.
    Vallee, J. -C. Duclos
    Samuel, D.
    Vittecoq, D.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S199 - S200
  • [46] HIV-1 integrase drug-resistance mutations in Iranian treatment-experienced HIV-1-infected patients
    Marjani, Arezoo
    Bokharaei-Salim, Farah
    Jahanbakhshi, Fatemeh
    Monavari, Seyed Hamidreza
    Esghaei, Maryam
    Kalantari, Saeed
    Kiani, Seyed Jalal
    Ataei-Pirkooh, Angila
    Fakhim, Atousa
    Keyvani, Hossein
    ARCHIVES OF VIROLOGY, 2020, 165 (01) : 115 - 125
  • [47] HIV-1 integrase drug-resistance mutations in Iranian treatment-experienced HIV-1-infected patients
    Arezoo Marjani
    Farah Bokharaei-Salim
    Fatemeh Jahanbakhshi
    Seyed Hamidreza Monavari
    Maryam Esghaei
    Saeed Kalantari
    Seyed Jalal Kiani
    Angila Ataei-Pirkooh
    Atousa Fakhim
    Hossein Keyvani
    Archives of Virology, 2020, 165 : 115 - 125
  • [48] HIV-1 reverse transcriptase (RT) mutations for HIV drug resistance surveillance and epidemiology: application to published studies of primary infection
    Shafer, R. W.
    Rhee, S. Y.
    Pillay, D.
    Dalwani, A.
    Miller, V.
    Sandstrom, P.
    Schapiro, J. M.
    Kuritzkes, D. R.
    Bennett, D.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S128 - S128
  • [49] Zero prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 drug-naive patients in and around Aligarh, India
    Azam, Mohd
    Malik, Abida
    Rizvi, Meher
    Rai, Arvind
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2014, 8 (01): : 79 - 85
  • [50] Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B
    Montes, B
    Vergne, L
    Peeters, M
    Reynes, J
    Delaporte, E
    Segondy, M
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (04) : 329 - 336
12345